• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者住院风险评估;一项多中心英国前瞻性观察研究。

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.

机构信息

Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.

British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, United Kingdom.

出版信息

PLoS One. 2020 Feb 10;15(2):e0228940. doi: 10.1371/journal.pone.0228940. eCollection 2020.

DOI:10.1371/journal.pone.0228940
PMID:32040531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7010290/
Abstract

In chronic obstructive pulmonary disease (COPD), acute exacerbation of COPD requiring hospital admission is associated with mortality and healthcare costs. The ERICA study assessed multiple clinical measures in people with COPD, including the short physical performance battery (SPPB), a simple test of physical function with 3 components (gait speed, balance and sit-to-stand). We tested the hypothesis that SPPB score would relate to risk of hospital admissions and length of hospital stay. Data were analysed from 714 of the total 729 participants (434 men and 280 women) with COPD. Data from this prospective observational longitudinal study were obtained from 4 secondary and 1 tertiary centres from England, Scotland, and Wales. The main outcome measures were to estimate the risk of hospitalisation with acute exacerbation of COPD (AECOPD and length of hospital stay derived from hospital episode statistics (HES). In total, 291 of 714 individuals experienced 762 hospitalised AECOPD during five-year follow up. Poorer performance of SPPB was associated with both higher rate (IRR 1.08 per 1 point decrease, 95% CI 1.01 to 1.14) and increased length of stay (IRR 1.18 per 1 point decrease, 95% CI 1.10 to 1.27) for hospitalised AECOPD. For the individual sit-to-stand component of the SPPB, the association was even stronger (IRR 1.14, 95% CI 1.02 to 1.26 for rate and IRR 1.32, 95% CI 1.16 to 1.49 for length of stay for hospitalised AECOPD). The SPPB, and in particular the sit-to-stand component can both evaluate the risk of H-AECOPD and length of hospital stay in COPD. The SPPB can aid in clinical decision making and when prioritising healthcare resources.

摘要

在慢性阻塞性肺疾病(COPD)中,需要住院治疗的 COPD 急性加重与死亡率和医疗保健成本相关。ERICA 研究评估了 COPD 患者的多项临床指标,包括简短体能测试(SPPB),这是一种具有 3 个组成部分(步态速度、平衡和坐站)的简单身体功能测试。我们检验了 SPPB 评分与住院风险和住院时间的相关性假设。数据分析来自 729 名 COPD 患者中的 714 名(434 名男性和 280 名女性)。这项前瞻性观察性纵向研究的数据来自英格兰、苏格兰和威尔士的 4 家二级和 1 家三级中心。主要结局测量指标是估计 COPD 急性加重(AECOPD)的住院风险和住院时间(根据医院发病统计数据(HES)得出)。在 5 年随访期间,714 人中共有 291 人经历了 762 例住院 AECOPD。SPPB 表现越差,住院 AECOPD 的发生率越高(IRR 每降低 1 分,1.08;95%CI 1.01 至 1.14),住院时间越长(IRR 每降低 1 分,1.18;95%CI 1.10 至 1.27)。对于 SPPB 的个体坐站组成部分,相关性甚至更强(IRR 1.14,95%CI 1.02 至 1.26 用于发病率,IRR 1.32,95%CI 1.16 至 1.49 用于住院 AECOPD 的住院时间)。SPPB,特别是坐站成分,均可评估 COPD 患者的 H-AECOPD 风险和住院时间。SPPB 可用于临床决策和优先考虑医疗保健资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/65da1e3d8ad7/pone.0228940.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/aa1cf7311852/pone.0228940.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/8e6537857adc/pone.0228940.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/65da1e3d8ad7/pone.0228940.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/aa1cf7311852/pone.0228940.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/8e6537857adc/pone.0228940.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6530/7010290/65da1e3d8ad7/pone.0228940.g003.jpg

相似文献

1
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.COPD 患者住院风险评估;一项多中心英国前瞻性观察研究。
PLoS One. 2020 Feb 10;15(2):e0228940. doi: 10.1371/journal.pone.0228940. eCollection 2020.
2
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
3
The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability.简短体能测试电池组是一种用于识别有残疾风险的慢性阻塞性肺疾病患者的鉴别工具。
Int J Chron Obstruct Pulmon Dis. 2015 Dec 3;10:2619-26. doi: 10.2147/COPD.S94377. eCollection 2015.
4
Short Physical Performance Battery: Response to Pulmonary Rehabilitation and Minimal Important Difference Estimates in Patients With Chronic Obstructive Pulmonary Disease.简短身体性能测试电池:对慢性阻塞性肺疾病患者的肺康复反应和最小重要差异估计。
Arch Phys Med Rehabil. 2021 Dec;102(12):2377-2384.e5. doi: 10.1016/j.apmr.2021.05.011. Epub 2021 Jun 25.
5
Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.与慢性阻塞性肺疾病(COPD)初级护理诊断后首次入院风险及急性加重再入院风险相关的患者特征:一项使用关联电子病历的队列研究
BMJ Open. 2016 Jan 22;6(1):e009121. doi: 10.1136/bmjopen-2015-009121.
6
Prediction of hospitalization stay in COPD exacerbations: the AECOPD-F score.慢性阻塞性肺疾病急性加重期住院时间的预测:AECOPD-F评分
Respir Care. 2014 Nov;59(11):1679-86. doi: 10.4187/respcare.03171. Epub 2014 Jun 24.
7
UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation.英国2003年慢性阻塞性肺疾病全国审计:急性慢性阻塞性肺疾病加重期入院后医院资源及护理组织对患者预后的影响。
Thorax. 2006 Oct;61(10):837-42. doi: 10.1136/thx.2005.049940. Epub 2006 Jan 31.
8
Performance-based functional assessment in older hospitalized patients: feasibility and clinical correlates.老年住院患者基于表现的功能评估:可行性及临床关联
J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1393-8. doi: 10.1093/gerona/63.12.1393.
9
Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.慢性阻塞性肺疾病严重加重期的身体状况、症状及健康相关生活质量:恢复情况及对未来事件的判别能力
Respir Med. 2023 Dec;220:107437. doi: 10.1016/j.rmed.2023.107437. Epub 2023 Nov 2.
10
Effect of time and day of admission on hospital care quality for patients with chronic obstructive pulmonary disease exacerbation in England and Wales: single cohort study.入院时间和日期对英格兰和威尔士慢性阻塞性肺疾病加重患者医院护理质量的影响:单队列研究
BMJ Open. 2017 Sep 6;7(9):e015532. doi: 10.1136/bmjopen-2016-015532.

引用本文的文献

1
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
2
Dysregulation of lipid mediators in patients with frequent exacerbations of COPD.慢性阻塞性肺疾病频繁急性加重患者脂质介质的失调
ERJ Open Res. 2025 Mar 24;11(2). doi: 10.1183/23120541.00950-2023. eCollection 2025 Mar.
3
A 7-point evidence-based care discharge protocol for patients hospitalized for exacerbation of COPD: consensus strategy and expert recommendation.

本文引用的文献

1
Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance.慢性阻塞性肺疾病:诊断与管理:英国国家卫生与临床优化研究所(NICE)最新指南摘要
BMJ. 2019 Jul 29;366:l4486. doi: 10.1136/bmj.l4486.
2
Building toolkits for COPD exacerbations: lessons from the past and present.构建 COPD 加重期的工具包:从过去到现在的经验教训。
Thorax. 2019 Sep;74(9):898-905. doi: 10.1136/thoraxjnl-2018-213035. Epub 2019 Jul 3.
3
Video Telehealth Pulmonary Rehabilitation Intervention in Chronic Obstructive Pulmonary Disease Reduces 30-Day Readmissions.
慢性阻塞性肺疾病急性加重住院患者基于证据的7点出院护理方案:共识策略与专家建议
NPJ Prim Care Respir Med. 2024 Dec 20;34(1):44. doi: 10.1038/s41533-024-00378-7.
4
Prevalence and prognostic importance of exercise limitation and physical inactivity in COPD.慢性阻塞性肺疾病(COPD)中运动受限和身体活动不足的患病率及预后重要性
Breathe (Sheff). 2024 Jun 11;20(2):230179. doi: 10.1183/20734735.0179-2023. eCollection 2024 Jun.
5
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis.探究慢性阻塞性肺疾病患者数字移动性结果的预后价值:一项系统文献综述和荟萃分析
Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0134-2023. Print 2023 Dec 31.
6
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA.循环睾酮水平与慢性阻塞性肺疾病的健康结局:来自 ECLIPSE 和 ERICA 的结果。
BMJ Open Respir Res. 2023 Jun;10(1). doi: 10.1136/bmjresp-2022-001601.
7
Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.选择性雄激素受体调节剂治疗慢性阻塞性肺疾病肌肉无力:一项随机对照试验。
Thorax. 2023 Mar;78(3):258-266. doi: 10.1136/thorax-2021-218360. Epub 2022 Oct 25.
8
Home-based Pulmonary Rehabilitation is Effective in Frail COPD Patients with Chronic Respiratory Failure.居家肺康复对合并慢性呼吸衰竭的虚弱慢性阻塞性肺疾病患者有效。
Chronic Obstr Pulm Dis. 2022 Jan 27;9(1):15-25. doi: 10.15326/jcopdf.2021.0250.
9
Recruiting patients to a digital self-management study whilst in hospital for a chronic obstructive pulmonary disease exacerbation: A feasibility analysis.在因慢性阻塞性肺疾病急性加重住院期间招募患者参与一项数字自我管理研究:可行性分析。
Digit Health. 2021 May 27;7:20552076211020876. doi: 10.1177/20552076211020876. eCollection 2021 Jan-Dec.
10
Jianpi Huatan Tongfu granule alleviates inflammation and improves intestinal flora in patients with acute exacerbation of chronic obstructive pulmonary disease.健脾化痰通腑颗粒可减轻慢性阻塞性肺疾病急性加重期患者的炎症反应,改善肠道菌群。
J Int Med Res. 2020 Apr;48(4):300060520909235. doi: 10.1177/0300060520909235.
视频远程医疗肺康复干预可降低慢性阻塞性肺疾病患者30天再入院率。
Am J Respir Crit Care Med. 2019 Aug 15;200(4):511-513. doi: 10.1164/rccm.201902-0314LE.
4
Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.纤维蛋白原与 COPD 患者的心血管或肌肉表现无关:来自 ERICA 研究的横断面数据。
Thorax. 2018 Dec;73(12):1182-1185. doi: 10.1136/thoraxjnl-2018-211556. Epub 2018 Apr 4.
5
Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial.远程监测在慢性阻塞性肺疾病(CHROMED)中的应用。一项随机临床试验。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):620-628. doi: 10.1164/rccm.201712-2404OC.
6
Prediction of long-term clinical outcomes using simple functional exercise performance tests in patients with COPD: a 5-year prospective cohort study.使用简单的功能性运动表现测试预测 COPD 患者的长期临床结局:一项为期 5 年的前瞻性队列研究。
Respir Res. 2017 Jun 2;18(1):112. doi: 10.1186/s12931-017-0598-6.
7
Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records.英国电子医疗记录中慢性阻塞性肺疾病急性加重住院情况的记录。
Clin Epidemiol. 2016 Nov 21;8:771-782. doi: 10.2147/CLEP.S117867. eCollection 2016.
8
Projecting the COPD population and costs in England and Scotland: 2011 to 2030.预测英格兰和苏格兰的 COPD 患者人群和费用:2011 年至 2030 年。
Sci Rep. 2016 Sep 1;6:31893. doi: 10.1038/srep31893.
9
The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.六分钟步行距离测试作为慢性阻塞性肺疾病分层工具。慢性阻塞性肺疾病生物标志物鉴定联盟的见解。
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1483-1493. doi: 10.1164/rccm.201508-1653OC.
10
Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design.采用药物和非药物联合干预提高慢性阻塞性肺疾病患者的运动耐量和身体活动能力:PHYSACTO随机、安慰剂对照研究设计
BMJ Open. 2016 Apr 13;6(4):e010106. doi: 10.1136/bmjopen-2015-010106.